Loading...
Loading...

Go to the content (press return)

A phase 1, randomized double-blind, placebo controlled trial to evaluate safety and efficacy of epigallocatechin-3-gallate and cognitive training in adults with Fragile X syndrome

Author
De la Torre, R.; de Sola, S.; Farré, M.; Xicota, L.; Cuenca, A.; Langohr, K.
Type of activity
Journal article
Journal
Clinical nutrition
Date of publication
2020-02-01
Volume
39
Number
2
First page
378
Last page
387
DOI
10.1016/j.clnu.2019.02.028
Repository
http://hdl.handle.net/2117/183508 Open in new window
URL
https://www.sciencedirect.com/science/article/pii/S0261561419300822 Open in new window
Abstract
© 2020. This manuscript version is made available under the CC-BY-NC-ND 4.0 license http://creativecommons.org/licenses/by-nc-nd/4.0/
Citation
De la Torre, R. [et al.]. A phase 1, randomized double-blind, placebo controlled trial to evaluate safety and efficacy of epigallocatechin-3-gallate and cognitive training in adults with Fragile X syndrome. "Clinical nutrition", 1 Febrer 2020, vol. 39, núm. 2, p. 378-387.
Keywords
Cognition, Epigallocatechin gallate, Fragile-X syndrome, Functionality
Group of research
GRBIO - Biostatistics and Bioinformatics Research Group

Participants

  • De la Torre Fornell, Rafael  (author)
  • de Sola Llopis, Susana  (author)
  • Farré, Magí  (author)
  • Xicota, Laura  (author)
  • Cuenca Royo, Aida  (author)
  • Langohr, Klaus  (author)